Hsp70 release from peripheral blood mononuclear cells
| dc.contributor.author | Hunter-Lavin, Claire | * |
| dc.contributor.author | Davies, Emma L. | * |
| dc.contributor.author | Bacelar, Maria M. F. V. G. | * |
| dc.contributor.author | Marshall, Michael J. | * |
| dc.contributor.author | Andrew, Sarah M. | * |
| dc.contributor.author | Williams, John H. H. | * |
| dc.date.accessioned | 2009-06-05T16:20:11Z | |
| dc.date.available | 2009-06-05T16:20:11Z | |
| dc.date.issued | 2004-11-12 | |
| dc.identifier.citation | Biochemical and Biophysical Research Communications, 324(2), 2004, pp. 511-517 | |
| dc.identifier.issn | 0006-291X | en |
| dc.identifier.issn | 1090-2104 | en |
| dc.identifier.doi | 10.1016/j.bbrc.2004.09.075 | |
| dc.identifier.uri | http://hdl.handle.net/10034/69814 | |
| dc.description | This article is not available through ChesterRep. | |
| dc.description.abstract | There are an increasing number of studies reporting the presence of Hsps in human serum. We have investigated the release of Hsp70 into blood and culture medium from peripheral blood mononuclear cells (PBMCs), and whether this release is due to cell damage or active secretion from the cells. Intact Hsp70 was released from cells within whole blood and from purified PBMCs under normal culture conditions. Hsp70 release was rapid (0.1 ng/106 cells/h) over the first 2 h of culture and continued at a reduced rate up to 24 h (<0.025 ng/106 cells/h). Using viable cell counts and lactate dehydrogenase release we were able to confirm that the release of Hsp70 was not due to cellular damage. Hsp70 release was inhibited by monensin, methyl-β-cyclodextrin, and methylamine, but not by brefeldin A. These data suggest that Hsp70 is released from cells via a non-classical pathway, possibly involving lysosomal lipid rafts. | |
| dc.description.sponsorship | This article was submitted to the RAE2008 for the University of Chester - Allied Health Professions and Studies. | |
| dc.language.iso | en | en |
| dc.publisher | Elsevier | |
| dc.relation.url | http://www.elsevier.com/wps/find/journaldescription.cws_home/622790/description#description | en |
| dc.subject | Hsp70 | en |
| dc.subject | peripheral blood mononuclear cells | en |
| dc.subject | lymphocytes | en |
| dc.subject | non-classical protein secretion | en |
| dc.title | Hsp70 release from peripheral blood mononuclear cells | en |
| dc.type | Article | en |
| dc.contributor.department | University of Chester ; University of Chester ; University of Chester ; The Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry ; University College Chester ; University College Chester | |
| dc.identifier.journal | Biochemical and Biophysical Research Communications | en |
| html.description.abstract | There are an increasing number of studies reporting the presence of Hsps in human serum. We have investigated the release of Hsp70 into blood and culture medium from peripheral blood mononuclear cells (PBMCs), and whether this release is due to cell damage or active secretion from the cells. Intact Hsp70 was released from cells within whole blood and from purified PBMCs under normal culture conditions. Hsp70 release was rapid (0.1 ng/106 cells/h) over the first 2 h of culture and continued at a reduced rate up to 24 h (<0.025 ng/106 cells/h). Using viable cell counts and lactate dehydrogenase release we were able to confirm that the release of Hsp70 was not due to cellular damage. Hsp70 release was inhibited by monensin, methyl-β-cyclodextrin, and methylamine, but not by brefeldin A. These data suggest that Hsp70 is released from cells via a non-classical pathway, possibly involving lysosomal lipid rafts. |
Files in this item
Name:
Publisher version